Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on December 14, 2017, reporting events occurring on December 8, 2017. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
The filing details a new debt financing arrangement rather than standard operating financial results. Key transaction metrics include:
- Promissory Note Principal: $1,587,500
- Purchase Price (Cash Proceeds): $1,100,000
- Original Issue Discount (OID): $462,500
- Transaction Expenses Included in Principal: $25,000
- Interest Rate: 8% per annum
- Maturity Date: September 8, 2018
- Use of Proceeds: General corporate purposes
Material Changes and Covenants
The company entered into a Securities Purchase Agreement and a Security Agreement with Chicago Venture Partners, L.P. (CVP). Material terms include:
- Security Interest: CVP received a security interest in substantially all of the Company's assets, effective upon the purchase of outstanding obligations under the Hercules Loan or upon full repayment of that loan.
- Redemption Rights: Beginning January 31, 2018, CVP has the right to redeem portions of the Note up to $350,000 per month for the first six months, and $500,000 per month thereafter. These limits aggregate with redemption amounts under a prior $2,155,000 note issued to CVP in June 2017.
- Covenants: The Company must timely file Exchange Act reports, maintain stock exchange listing, avoid trading suspensions, and obtain CVP consent before issuing variable securities generating less than $1 million or granting security interests in assets.
- Subordination: The new debt is subordinate to the Company's indebtedness to Hercules Capital, Inc., pursuant to a prior Subordination Agreement.
Guidance, Outlook, and Risks
The filing does not provide specific revenue guidance, profit outlook, or management commentary on future operating performance. The primary risk disclosed relates to the Company's liquidity and debt obligations, specifically the redemption rights held by CVP and the requirement to maintain compliance with reporting and listing covenants to avoid liquidated damages.
Investor Verification Checklist
- Verify the total outstanding debt balance, including the new $1,587,500 note and the prior $2,155,000 note to CVP.
- Confirm the status of the Hercules Capital, Inc. loan and whether the security interest granted to CVP has become effective.
- Review the Company's cash position to assess its ability to meet the monthly redemption obligations starting January 31, 2018.
- Check for any subsequent filings regarding the issuance of variable securities or additional debt that may require CVP consent.